Dopamine transporter density of the basal ganglia assessed with [ 123I]IPT SPECT in drug-naive children with Tourette's disorder

Keun Ah Cheon, Young Hoon Ryu, Kee Namkoong, Chan Hyung Kim, Jae-Jin Kim, Jong Doo Lee

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

There is evidence that abnormalities in the dopaminergic system involving the dopamine transporter (DAT) are involved in the pathophysiology of Tourette's disorder (TD) from previous studies using [123I]2β- carbomethoxy-3-(4-iodophenyl)tropane ([123I]β-CIT) and single photon emission tomography (SPECT). However, because those studies were performed in medicated adult patients with TD, we decided to compare DAT densities in nine drug-naive children with TD and eight normal children. The children with TD did not suffer from associated psychiatric problems such as obsessive-compulsive symptoms, attention deficit hyperactivity disorder, anxiety, depression and developmental difficulties. We performed brain SPECT 2 h after the intravenous administration of I-123N-(3-iodopropen-2-yl)-2β- carbomethoxy-3beta-(4-chlorophenyl)tropane ([123I]IPT) and carried out both quantitative and qualitative analyses using the obtained SPECT data, which were reconstructed for the assessment of the specific/non-specific DAT binding ratio in the basal ganglia. We then investigated the correlation between the severity of tics in children with TD assessed with the Yale Global Tic Severity Scale (YGTSS) and the specific/non-specific DAT binding ratio of the basal ganglia. Drug-naive children with TD showed a significantly increased specific/non-specific DAT binding ratio in the basal ganglia compared with normal children that did not correlate significantly with the severity of tics. Our results with drug-naive children with TD between the ages of 6 and 12 may help to clarify previous findings concerning DAT binding in adult patients with TD and suggest that DAT densities may be associated directly with the pathophysiology of TD, regardless of disease progress or drug effect.

Original languageEnglish
Pages (from-to)85-95
Number of pages11
JournalPsychiatry Research - Neuroimaging
Volume130
Issue number1
DOIs
Publication statusPublished - 2004 Jan 15

Fingerprint

Tourette Syndrome
Dopamine Plasma Membrane Transport Proteins
Basal Ganglia
Single-Photon Emission-Computed Tomography
Pharmaceutical Preparations
Tics
Tropanes
N-(3-iodopropen-1-yl)-2-carbomethoxy-3-(4-chlorophenyl)tropane
Attention Deficit Disorder with Hyperactivity
Photons
Intravenous Administration
Psychiatry
Anxiety
Tomography
Depression

All Science Journal Classification (ASJC) codes

  • Neuroscience (miscellaneous)
  • Radiology Nuclear Medicine and imaging
  • Psychiatry and Mental health

Cite this

Cheon, Keun Ah ; Ryu, Young Hoon ; Namkoong, Kee ; Kim, Chan Hyung ; Kim, Jae-Jin ; Lee, Jong Doo. / Dopamine transporter density of the basal ganglia assessed with [ 123I]IPT SPECT in drug-naive children with Tourette's disorder. In: Psychiatry Research - Neuroimaging. 2004 ; Vol. 130, No. 1. pp. 85-95.
@article{59427bd019dd4d91b2f1303cf3a38f26,
title = "Dopamine transporter density of the basal ganglia assessed with [ 123I]IPT SPECT in drug-naive children with Tourette's disorder",
abstract = "There is evidence that abnormalities in the dopaminergic system involving the dopamine transporter (DAT) are involved in the pathophysiology of Tourette's disorder (TD) from previous studies using [123I]2β- carbomethoxy-3-(4-iodophenyl)tropane ([123I]β-CIT) and single photon emission tomography (SPECT). However, because those studies were performed in medicated adult patients with TD, we decided to compare DAT densities in nine drug-naive children with TD and eight normal children. The children with TD did not suffer from associated psychiatric problems such as obsessive-compulsive symptoms, attention deficit hyperactivity disorder, anxiety, depression and developmental difficulties. We performed brain SPECT 2 h after the intravenous administration of I-123N-(3-iodopropen-2-yl)-2β- carbomethoxy-3beta-(4-chlorophenyl)tropane ([123I]IPT) and carried out both quantitative and qualitative analyses using the obtained SPECT data, which were reconstructed for the assessment of the specific/non-specific DAT binding ratio in the basal ganglia. We then investigated the correlation between the severity of tics in children with TD assessed with the Yale Global Tic Severity Scale (YGTSS) and the specific/non-specific DAT binding ratio of the basal ganglia. Drug-naive children with TD showed a significantly increased specific/non-specific DAT binding ratio in the basal ganglia compared with normal children that did not correlate significantly with the severity of tics. Our results with drug-naive children with TD between the ages of 6 and 12 may help to clarify previous findings concerning DAT binding in adult patients with TD and suggest that DAT densities may be associated directly with the pathophysiology of TD, regardless of disease progress or drug effect.",
author = "Cheon, {Keun Ah} and Ryu, {Young Hoon} and Kee Namkoong and Kim, {Chan Hyung} and Jae-Jin Kim and Lee, {Jong Doo}",
year = "2004",
month = "1",
day = "15",
doi = "10.1016/j.pscychresns.2003.06.001",
language = "English",
volume = "130",
pages = "85--95",
journal = "Psychiatry Research - Neuroimaging",
issn = "0925-4927",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

Dopamine transporter density of the basal ganglia assessed with [ 123I]IPT SPECT in drug-naive children with Tourette's disorder. / Cheon, Keun Ah; Ryu, Young Hoon; Namkoong, Kee; Kim, Chan Hyung; Kim, Jae-Jin; Lee, Jong Doo.

In: Psychiatry Research - Neuroimaging, Vol. 130, No. 1, 15.01.2004, p. 85-95.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Dopamine transporter density of the basal ganglia assessed with [ 123I]IPT SPECT in drug-naive children with Tourette's disorder

AU - Cheon, Keun Ah

AU - Ryu, Young Hoon

AU - Namkoong, Kee

AU - Kim, Chan Hyung

AU - Kim, Jae-Jin

AU - Lee, Jong Doo

PY - 2004/1/15

Y1 - 2004/1/15

N2 - There is evidence that abnormalities in the dopaminergic system involving the dopamine transporter (DAT) are involved in the pathophysiology of Tourette's disorder (TD) from previous studies using [123I]2β- carbomethoxy-3-(4-iodophenyl)tropane ([123I]β-CIT) and single photon emission tomography (SPECT). However, because those studies were performed in medicated adult patients with TD, we decided to compare DAT densities in nine drug-naive children with TD and eight normal children. The children with TD did not suffer from associated psychiatric problems such as obsessive-compulsive symptoms, attention deficit hyperactivity disorder, anxiety, depression and developmental difficulties. We performed brain SPECT 2 h after the intravenous administration of I-123N-(3-iodopropen-2-yl)-2β- carbomethoxy-3beta-(4-chlorophenyl)tropane ([123I]IPT) and carried out both quantitative and qualitative analyses using the obtained SPECT data, which were reconstructed for the assessment of the specific/non-specific DAT binding ratio in the basal ganglia. We then investigated the correlation between the severity of tics in children with TD assessed with the Yale Global Tic Severity Scale (YGTSS) and the specific/non-specific DAT binding ratio of the basal ganglia. Drug-naive children with TD showed a significantly increased specific/non-specific DAT binding ratio in the basal ganglia compared with normal children that did not correlate significantly with the severity of tics. Our results with drug-naive children with TD between the ages of 6 and 12 may help to clarify previous findings concerning DAT binding in adult patients with TD and suggest that DAT densities may be associated directly with the pathophysiology of TD, regardless of disease progress or drug effect.

AB - There is evidence that abnormalities in the dopaminergic system involving the dopamine transporter (DAT) are involved in the pathophysiology of Tourette's disorder (TD) from previous studies using [123I]2β- carbomethoxy-3-(4-iodophenyl)tropane ([123I]β-CIT) and single photon emission tomography (SPECT). However, because those studies were performed in medicated adult patients with TD, we decided to compare DAT densities in nine drug-naive children with TD and eight normal children. The children with TD did not suffer from associated psychiatric problems such as obsessive-compulsive symptoms, attention deficit hyperactivity disorder, anxiety, depression and developmental difficulties. We performed brain SPECT 2 h after the intravenous administration of I-123N-(3-iodopropen-2-yl)-2β- carbomethoxy-3beta-(4-chlorophenyl)tropane ([123I]IPT) and carried out both quantitative and qualitative analyses using the obtained SPECT data, which were reconstructed for the assessment of the specific/non-specific DAT binding ratio in the basal ganglia. We then investigated the correlation between the severity of tics in children with TD assessed with the Yale Global Tic Severity Scale (YGTSS) and the specific/non-specific DAT binding ratio of the basal ganglia. Drug-naive children with TD showed a significantly increased specific/non-specific DAT binding ratio in the basal ganglia compared with normal children that did not correlate significantly with the severity of tics. Our results with drug-naive children with TD between the ages of 6 and 12 may help to clarify previous findings concerning DAT binding in adult patients with TD and suggest that DAT densities may be associated directly with the pathophysiology of TD, regardless of disease progress or drug effect.

UR - http://www.scopus.com/inward/record.url?scp=1242337468&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1242337468&partnerID=8YFLogxK

U2 - 10.1016/j.pscychresns.2003.06.001

DO - 10.1016/j.pscychresns.2003.06.001

M3 - Article

C2 - 14972371

AN - SCOPUS:1242337468

VL - 130

SP - 85

EP - 95

JO - Psychiatry Research - Neuroimaging

JF - Psychiatry Research - Neuroimaging

SN - 0925-4927

IS - 1

ER -